These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 26541795

  • 1. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH.
    Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
    [Abstract] [Full Text] [Related]

  • 2. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R.
    Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
    [Abstract] [Full Text] [Related]

  • 3. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
    Bisecco A, Stamenova S, Caiazzo G, d'Ambrosio A, Sacco R, Docimo R, Esposito S, Cirillo M, Esposito F, Bonavita S, Tedeschi G, Gallo A.
    Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW, Park G, Kwak K, Jo HJ, Joung A, Kim JH, Lee SH, Kim S, Lee JM, Kim SH, Kim HJ.
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [Abstract] [Full Text] [Related]

  • 6. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Buś K, Leszczyński P, Puszczewicz M, Majewski D, Paprzycki W, Kozubski W, Michalak S.
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [Abstract] [Full Text] [Related]

  • 7. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R, Hurwitz S, Tauhid S, Bakshi R.
    BMC Neurol; 2017 Sep 05; 17(1):172. PubMed ID: 28874119
    [Abstract] [Full Text] [Related]

  • 8. Association between Deep Gray Matter Changes and Neurocognitive Function in Mild Cognitive Impairment and Alzheimer's Disease: A Tensor-Based Morphometric MRI Study.
    Tuokkola T, Karrasch M, Koikkalainen J, Parkkola R, Lötjönen J, Löyttyniemi E, Hurme S, Rinne JO.
    Dement Geriatr Cogn Disord; 2019 Sep 05; 48(1-2):68-78. PubMed ID: 31514198
    [Abstract] [Full Text] [Related]

  • 9. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM, Zurawski J, Chu R, Tie Y, Tauhid S, Quattrucci M, Healy BC, Bakshi R.
    J Neurol; 2024 Oct 05; 271(10):6935-6943. PubMed ID: 39240345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
    Debernard L, Melzer TR, Alla S, Eagle J, Van Stockum S, Graham C, Osborne JR, Dalrymple-Alford JC, Miller DH, Mason DF.
    Psychiatry Res; 2015 Dec 30; 234(3):352-61. PubMed ID: 26602610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
    Magon S, Tsagkas C, Gaetano L, Patel R, Naegelin Y, Amann M, Parmar K, Papadopoulou A, Wuerfel J, Stippich C, Kappos L, Chakravarty MM, Sprenger T.
    J Neurol; 2020 May 30; 267(5):1536-1546. PubMed ID: 32040710
    [Abstract] [Full Text] [Related]

  • 16. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
    Hernández-Torres E, Wiggermann V, Machan L, Sadovnick AD, Li DKB, Traboulsee A, Hametner S, Rauscher A.
    J Magn Reson Imaging; 2019 Jul 30; 50(1):201-208. PubMed ID: 30511803
    [Abstract] [Full Text] [Related]

  • 17. Quantitative Susceptibility Mapping Values Quantification in Deep Gray Matter Structures for Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mohammadi S, Ghaderi S, Fatehi F.
    Brain Behav; 2024 Oct 30; 14(10):e70093. PubMed ID: 39415615
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul 30; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.